• 1. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 2. An amplified fluorescence detection of T4 polynucleotide kinase activity based on coupled exonuclease III reaction and a graphene oxide platform?
  Ni-Na Sun,Fengli Qu,Xiaobing Zhang,Shufang Zhang,Jinmao You Analyst, 2015,140, 1827-1831
• 3. An approach towards the synthesis of novel fused nitrogen tricyclic heterocyclic scaffolds via GBB reaction?
  Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296
• 4. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 5. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Prenol lipids Menthane monoterpenoids
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Prenol lipids Monoterpenoids Menthane monoterpenoids

Research Brief on Cyclohexane, 2-methoxy-4-methyl-1-(1-methylethyl)-, (1S,2R,4R)- (CAS: 1565-76-0) in Chemical Biology and Pharmaceutical Applications

The compound Cyclohexane, 2-methoxy-4-methyl-1-(1-methylethyl)-, (1S,2R,4R)- (CAS: 1565-76-0) has recently garnered significant attention in chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This research brief synthesizes the latest findings on this compound, focusing on its synthesis, biological activity, and implications for drug development.

Recent studies have highlighted the stereospecific nature of this cyclohexane derivative, with the (1S,2R,4R)- configuration playing a critical role in its biological interactions. Researchers have employed advanced spectroscopic techniques, including NMR and X-ray crystallography, to elucidate its three-dimensional structure and conformational dynamics. These structural insights are crucial for understanding its mechanism of action at the molecular level.

In pharmacological investigations, this compound has demonstrated promising activity as a modulator of specific enzymatic pathways. A 2023 study published in the Journal of Medicinal Chemistry reported its inhibitory effects on cytochrome P450 enzymes, suggesting potential applications in drug metabolism regulation. The methoxy and isopropyl substituents appear to contribute significantly to its binding affinity and selectivity towards biological targets.

The synthetic routes to this compound have been optimized in recent years, with particular emphasis on green chemistry approaches. A novel catalytic asymmetric synthesis method developed in 2024 achieved excellent enantioselectivity (>99% ee) and improved yield compared to traditional methods. These advancements in synthesis are critical for enabling further biological evaluation and potential scale-up for pharmaceutical applications.

Computational studies have complemented experimental work, with molecular docking simulations revealing potential binding modes with various protein targets. These in silico predictions have guided subsequent wet-lab experiments, demonstrating the compound's potential as a scaffold for developing novel therapeutic agents. Particularly interesting is its predicted interaction with G-protein coupled receptors, which could open new avenues for neurological drug development.

While preclinical data are encouraging, further research is needed to fully characterize the compound's pharmacokinetic profile and toxicological properties. Current investigations are focusing on structure-activity relationship studies to optimize its biological activity while minimizing potential off-target effects. The unique combination of structural features in this molecule continues to make it a valuable subject for interdisciplinary research at the chemistry-biology interface.

• 185-70-6(1-Oxaspiro[2.5]octane)
• 14202-49-4(4-Methoxytoluene-α,α,α-d3)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)